Azobar: Enhancing Antibacterial Defense

Description:

Azobar, available in tablet and dry suspension forms, leverages the antibacterial power of Azithromycin. Its tablet variants, Azobar 250mg and Azobar 500mg, and the dry suspension, Azobar 200mg/5ml, cater to various infection severities. Azithromycin dihydrate, the active ingredient, ensures an effective molecular formula that combats susceptible microorganisms.

Clinical Particulars:

Therapeutic Indications:

Azobar treats mild to moderate infections caused by susceptible strains of various microorganisms. In adults, it covers conditions like acute bacterial sinusitis, bronchitis exacerbations, community-acquired pneumonia, and skin infections. Pediatric applications include otitis media, sinusitis, and pneumonia.

Limitations of Use:

Patients with severe illness, cystic fibrosis, and nosocomial infections should exercise caution. Azithromycin ought not to substitute first-line therapy for specific conditions, and doctors do not recommend it for pneumonia patients deemed unsuitable for oral therapy.

Usage Guidelines:

Only use Azithromycin when infections are proven or strongly suspected to be caused by susceptible bacteria to mitigate the development of drug-resistant bacteria. Dosages and durations vary based on the specific infection and patient population.

Adverse Reactions and Warnings:

Adverse Effects:

Common reactions include gastrointestinal symptoms (nausea, diarrhea), allergic reactions, hepatotoxicity, and infantile hypertrophic pyloric stenosis (in neonates). Reported effects also include prolonged cardiac repolarization, Clostridium difficile-associated diarrhea, and exacerbation of myasthenia gravis.

Warnings:

Physicians should monitor patients closely for signs of allergic reactions, hepatotoxicity, and QT prolongation. Caution is advised in patients with myasthenia gravis. Azithromycin is not the primary choice for treating syphilis.

Mechanism of Action and Pharmacokinetics:

Action:

Azithromycin binds to the 23s rRNA of the 50S ribosomal subunit, inhibiting bacterial protein synthesis and disrupting the assembly of the 50S ribosomal subunit.

Pharmacokinetics:

Food influences Azithromycin’s bioavailability, resulting in low concentrations observed in cerebrospinal fluid. Drug clearance is affected by renal impairment, and the impact of hepatic impairment is yet to be established.

Use in Specific Populations:

Based on limited data, safety is suggested during pregnancy, while caution is advised during breastfeeding.

In treating pediatric infections, Azithromycin has established safety, although conclusive data may be lacking for specific age groups.

Elderly and younger subjects showed no significant differences in safety observations.

How Supplied and Storage:

Azobar is available in blister packs for tablets and bottles for dry suspension. Proper storage below 30°C is essential, with expiration dates indicating product integrity.

Instructions:

Keep Azobar away from moisture, heat, light, and children. Dispensation requires a registered medical practitioner’s prescription. Always read the package insert for updated information.

Azobar stands as a versatile antibacterial solution, balancing efficacy and safety across diverse patient demographics.